American Lung Association (ALA) Lung Health Cohort (NCT04543461)
The American Lung Association (ALA) Lung Health Cohort
🩺 Plain-English Summary (8th-Grade Level)
The ALA-LHC is a longitudinal, multi-center cohort study that will enroll approximately 4,000 young adults between the ages of 25-35 who do not have severe lung disease. The overarching objective of the ALA-LHC is to establish a national cohort of young adults for the purpose of defining lung health and developing targets to intercept chronic lung disease at its earliest stages.
Who can join: Review the eligibility criteria below.
Location: University Of Alabama — Birmingham, Alabama
Age range: 25 Years to 35 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (37 Sites)
Showing the first 25 of 37 sites.
- University Of Alabama — Birmingham, Alabama
- University of Arizona-Tuscon — Tucson, Arizona
- University of California, Los Angeles — Los Angeles, California
- University of California, San Francisco — San Francisco, California
- University of Colorado — Aurora, Colorado
- National Jewish Health — Denver, Colorado
- Nemours Children's Jacksonville — Jacksonville, Florida
- University of Florida, Jacksonville — Jacksonville, Florida
- University of Illinois at Chicago — Chicago, Illinois
- Northwestern University — Chicago, Illinois
- Rush Universtiy — Chicago, Illinois
- University of Chicago — Chicago, Illinois
- St. Vincent's Health System — Indianapolis, Indiana
- University of Iowa — Iowa City, Iowa
- University of Kansas — Kansas City, Kansas
- Johns Hopkins University — Baltimore, Maryland
- Brigham and Women's — Boston, Massachusetts
- University of Michigan — Ann Arbor, Michigan
- Presbyterian Brooklyn Methodist Hospital — Brooklyn, New York
- New York Medical College — Hawthorne, New York
- New York University — New York, New York
- Mt. Sinai, NYC — New York, New York
- Columbia University — New York, New York
- Cornell University — New York, New York
- University of Rochester — Rochester, New York
📞 Contact the Study Coordinator
Phone: (443) 287-3170
Email: esugar2@jhu.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Lung Diseases
- CF Bronchodilation — Vancouver, British Columbia
- Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers — Tampa, Florida
- Data Collection For Adventitious Lung Sounds Algorithm Using Eko Digital Devices in a Clinical Setting — Forney, Texas
- Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients — Miami, Florida
- Defining a Technique for the Use of Cryogenic Catheters for Biopsy and Ablation for the Diagnostic and Treatment of Pulmonary Lesions: An Ex-Vivo Human Lung Model Study. — Montreal, Quebec
- Cough Capture as a Portal Into the Lung — The Bronx, New York
Explore by condition: All Lung Diseases clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.